Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Glaxo to submit NDA in Japan for lamivudine in hepatitis

May 27, 1997

Anti-H. pylori agents disclosed by Roussel Morishita

May 26, 1997

Novavax to initiate dose-ranging trial of Helicore

May 23, 1997

Salix reports promising clinical results for ulcerative colitis treatment

May 16, 1997

NIH announces prospective grant of licenses for IL-12 antibodies

May 16, 1997

Centocor reports results from Crohn's disease studies

May 14, 1997

Low-dose oral IFN-alpha + high-dose injectable IFN-alpha for hepatitis C

May 14, 1997

Data from U.K. phase III trial of Zacutex presented

May 13, 1997

Hepatoprotective effects of ET antagonist TAK-044

May 12, 1997

Orphan Medical's medicated chewing gum reduces stomach levels of H. pylori

May 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.